Publications
295
Citations
7,602
Est. group size
—
Recurring co-author estimate
Active years
61
Publishing since 1965
David S.H. Bell conducts clinical research in medicine focused on diabetes and its complications. Recent work examines the management of type 1 and type 2 diabetes, diabetic nerve and kidney complications, and the use of newer drug therapies such as GLP-1 receptor agonists (medications originally developed for diabetes that also affect weight). Much of the output takes the form of clinical case reports, reviews, and commentary in endocrinology and diabetes journals.
Publication activity grew notably from around 2020, peaking in 2022, and has remained active in recent years, averaging roughly nine publications per year over the last five years.
Generated by claude-opus-4-8 from public bibliographic data · Jul 9, 2026
No award with a current end date on record.
2 earlier awards
- NSF 1828237Sep 2018 – Aug 2021 · $1.1M awarded
MRI: Acquisition of an Aberration Corrected Low Energy Electron Microscope (AC-LEEM) for high resolution spectroscopic imaging of surfaces
- NIH R01HD055826Apr 2008 – Mar 2014 · $305k awarded
Networks of Heterosexual Risk and HIV
Matched to public NIH RePORTER and NSF records by name and institution. Awards from other agencies are not shown, and a match is not always found — this list may be incomplete.
Typically publishes in teams of ~2 · 94% small-team papers (≤3 authors) · across 18 venues
- Diabetic distal symmetric polyneuropathy: More than just “tingling in the feet”
Diabetes Obesity and Metabolism · 2025
- In adults with obesity and knee OA, adding weekly semaglutide to diet and activity counseling reduced weight and knee pain at 68 wk
Annals of Internal Medicine · 2025
- Pseudoascites Due to Celiac Disease in a Patient with Type 1 Diabetes
Diabetes Therapy · 2025
- Successful Utilization of the GLP-1 Receptor Agonist Semaglutide in Treating the Manifestations of Recalcitrant Celiac Disease
Archives of Clinical and Biomedical Research · 2025
- Author response for "Diabetic distal symmetric polyneuropathy: More than just “tingling in the feet”"
2025
- Author response for "Diabetic distal symmetric polyneuropathy: More than just “tingling in the feet”"
2025
- No, It Doesn’t Go Without Saying: Energy Justice, Public Investment, and Social Entrepreneurship—A Clean Energy Heuristic
Public Integrity · 2025
- The Role of Teplizumab in Newly Diagnosed Type 1 Diabetes
Endocrine Practice · 2024
- Review for "Efficacy of Aspirin for primary prevention among adults with high‐risk type 2 diabetes in the <scp>ACCORD</scp> trial"
2024
- Review for "Efficacy of Aspirin for primary prevention among adults with high‐risk type 2 diabetes in the <scp>ACCORD</scp> trial"
2024
- Review for "Semaglutide use in people with obesity and type 2 diabetes from real‐world utilization data: An analysis of the All of US Program"
2024
- The potential for improved outcomes in the prevention and therapy of diabetic kidney disease through ‘stacking’ of drugs from different classes
Diabetes Obesity and Metabolism · 2024
- Obesity and abdominal hernia in ambulatory patients, 2018–2023
Hernia · 2024
- Diabetic Charcot neuroarthropathy: A threat to both limb and life
Diabetes Obesity and Metabolism · 2024
- Exogenous Insulin Antibody Syndrome (EIAS) Presenting in an Elderly, Long-Term Patient with Type 1 Diabetes Mellitus that Resolved with Low-Cost Outpatient Therapy with Mycophenolate Mofetil and Regular Insulin by Pump
Diabetes Therapy · 2024
- Diabetes Obesity and Metabolism×15
- Diabetes Therapy×10
- Endocrine Practice×4
- Frontiers in Medical Case Reports×4
- Annals of Internal Medicine×2
- Ionut Bebu
Medicine · University of Michigan
- Mark R. Burge
Medicine · University of Michigan
- Elizabeth R. Seaquist
Medicine · University of Michigan
- Catherine L. Martin
Medicine · University of Michigan
- Robin Goland
Medicine · University of Michigan
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Sep 1, 2026.
Claim or correct this profile